Table 2.
FB+/CB+/S+ | FB+/CB+/S− | FB+/CB−/S+ | FB+/CB−/S− | |||||
---|---|---|---|---|---|---|---|---|
C | AXO | C | AXO | C | AXO | C | AXO | |
TH | 33.4 ± 4.7 | 16.8 ± 3.5 | 3.1 ± 1.3 | 14.5 ± 3.2 | 54.4 ± 5.2 | 44.2 ± 3.7 | 6.9 ± 1.6 | 24.4 ± 3.0 |
NPY | 25.1 ± 3.8 | 1.4 ± 0.4 | 3.8 ± 0.8 | 36.0 ± 1.0 | 58.9 ± 2.5 | 41.6 ± 1.5 | 12.2 ± 2.2 | 21.0 ± 2.5 |
SOM | 11.1 ± 1.3 | 3.4 ± 0.1 | 18.7 ± 2.8 | 37.2 ± 8.0 | 7.6 ± 3.2 | 0.3 ± 0.2 | 62.3 ± 1.3 | 59.1 ± 8.8 |
VIP | 1.5 ± 1.0 | 0 | 39.6 ± 3.5 | 33.3 ± 7.1 | 3.5 ± 0.9 | 1.3 ± 1.3 | 62.3 ± 1.3 | 65.7 ± 8.0 |
NOS | 0 | 0 | 34.7 ± 4.0 | 37.5 ± 7.5 | 1.8 ± 0.8 | 0 | 63.5 ± 2.7 | 62.5 ± 7.5 |
LENK | 0 | 0 | 31.9 ± 1.9 | 27.3 ± 6.5 | 1.4 ± 0.8 | 5.8 ± 1.6 | 67.0 ± 2.9 | 67.2 ± 0.8 |
SP | 0 | 0 | 35.7 ± 1.5 | 35.3 ± 5.6 | 0 | 0 | 64.5 ± 2.5 | 64.7 ± 5.7 |
VAChT | 0 | 0 | 39.3 ± 1.8 | 36.3 ± 6.0 | 0 | 0 | 62.7 ± 1.8 | 63.8 ± 6.0 |
GAL | 0 | 0 | 38.3 ± 1.8 | 37.3 ± 7.0 | 0 | 0 | 61.7 ± 1.8 | 62.8 ± 7.0 |
Data were expressed as mean ± standard deviation (SD)
S studied substance (NPY, SOM, VIP, etc.)